➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
AstraZeneca
Medtronic
McKesson
Dow

Last Updated: November 25, 2020

DrugPatentWatch Database Preview

Claims for Patent: 8,071,623

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,071,623
Title:Amide substituted indazoles as poly(ADP-ribose)polymerase(PARP) inhibitors
Abstract: The present invention relates to compounds of formula I: ##STR00001## and pharmaceutically acceptable salts, stereoisomers or tautomers thereof which are inhibitors of poly (ADP-ribose) polymerase (PARP) and thus useful for the treatment of cancer, inflammatory diseases, reperfusion injuries, ischemic conditions, stroke, renal failure, cardiovascular diseases, vascular diseases other than cardiovascular diseases, diabetes, neurodegenerative diseases, retroviral infection, retinal damage or skin senescence and UV-induced skin damage, and as chemo- and/or radiosensitizers for cancer treatment.
Inventor(s): Jones; Philip (Rome, IT), Ontoria Ontoria; Jesus Maria (Rome, IT), Scarpelli; Rita (Rome, IT), Schultz-Fademrecht; Carsten (Rome, IT)
Assignee: Instituto di Ricerche di Biologia Molecolare P. Angeletti SpA (Rome, unknown)
Application Number:12/006,993
Patent Claims: 1. A compound of formula I: ##STR00020## wherein: R.sup.1 is hydrogen or fluorine; and R.sup.2 is hydrogen or fluorine; or pharmaceutically acceptable salts, stereoisomers or tautomers thereof.

2. A compound of claim 1 of formula II: ##STR00021## wherein R.sup.1 and R.sup.2 are as defined in claim 1; or pharmaceutically acceptable salts, stereoisomers or tautomers thereof.

3. A compound of claim 1 of formula III: ##STR00022## wherein R.sup.1 and R.sup.2 are as defined in claim 1; or pharmaceutically acceptable salts or tautomers thereof.

4. A compound of claim 1 of formula IV: ##STR00023## wherein R.sup.1 and R.sup.2 are as defined in claim 1; or pharmaceutically acceptable salts or tautomers thereof.

5. A compound of claim 1 selected from: 2-(4-Piperidin-3-ylphenyl)-2H-indazole-7-carboxamide; 2-{4-[(3R)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide; 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide; 5-fluoro-2-(4-piperidin-3-ylphenyl)-2H-indazole-7-carboxamide; 5-fluoro-2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide; 5-fluoro-2-{4-[(3R)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide; 5-fluoro-2-(3-fluoro-4-piperidin-3-ylphenyl)-2H-indazole-7-carboxamide; 5-fluoro-2-{3-fluoro-4-[(3R)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxa- mide; 5-fluoro-2-{3-fluoro-4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-ca- rboxamide; and pharmaceutically acceptable salts, tautomers or stereoisomers thereof.

6. A compound of claim 5 selected from: 2-{4-[(3R)-Piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide; 2-{4-[(3S)-Piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide; and pharmaceutically acceptable salts or tautomers thereof.

7. A compound which is: 2-(4-Piperidin-3-ylphenyl)-2H-indazole-7-carboxamide; and pharmaceutically acceptable salts or tautomers thereof.

8. A compound which is: 2-{4-[(3S)-Piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide; and pharmaceutically acceptable salts or tautomers thereof.

9. A pharmaceutical composition comprising a compound of claim 1, or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof in association with a pharmaceutically acceptable carrier.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Mallinckrodt
Colorcon
McKinsey
McKesson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.